COVID-19 battle begins in the nose

A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered.

Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections

Probing innate immunity

Manuel Ascano team validates an inhibitor of the cGAS-STING signaling pathway, which is important for cellular innate immunity against bacteria, viruses, and our own damaged DNA.

RSV-HRV viral interference

RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants.

Enzyme holds the door for influenza

Compounds developed at Vanderbilt University may offer a new way to block influenza infection.

Neural receptor for reovirus

A newly identified receptor allows mammalian reovirus to infect neurons, shedding light on factors important for viral encephalitis.